Babak Orandi, MD, PhD

TitleClinical Fellow
SchoolUCSF School of Medicine
Address505 Parnassus Avenue
San Francisco CA 94143
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Quantifying Risk and Survival Benefit from Incompatible Kidney Transplantation
    NIH/NIDDK F32DK093218Jan 7, 2012 - Jan 6, 2015
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Orandi B, Montgomery RA, Segev DL. Kidney Transplants from HLA-Incompatible Live Donors and Survival. N Engl J Med. 2016 Jul 21; 375(3):288-9. PMID: 27468073.
      View in: PubMed
    2. Limketkai BN, Orandi B, Luo X, Segev DL, Colombel JF, et al. Mortality and Rates of Graft Rejection or Failure Following Intestinal Transplantation in Patients With vs Without Crohn's Disease. Clin Gastroenterol Hepatol. 2016 Jun 29. PMID: 27374004.
      View in: PubMed
    3. Ahmed R, Bae S, Hicks CW, Orandi B, Atallah C, Chow EK, Massie AB, Lopez J, Higgins RS, Segev DL, et al. Here comes the Sun Shine: Industry's Payments to Cardiothoracic Surgeons. Ann Thorac Surg. 2016 Jun 25. PMID: 27353195.
      View in: PubMed
    4. Fahmy LM, Massie AB, Muzaale AD, Bagnasco SM, Orandi B, Alejo JL, Boyarsky BJ, Anjum SK, Montgomery RA, Dagher NN, Segev DL. Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation. Transplantation. 2016 Jun; 100(6):1294-8. PMID: 27152920.
      View in: PubMed
    5. Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi B, McAdams-DeMarco M, Grams ME, Segev DL. Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus. Am J Transplant. 2016 Aug; 16(8):2368-76. PMID: 27111897.
      View in: PubMed
    6. Orandi B, Lonze BE, Jackson A, Terezakis S, Kraus ES, Alachkar N, Bagnasco SM, Segev DL, Orens JB, Montgomery RA, et al. Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. Am J Transplant. 2016 May 23. PMID: 27214874.
      View in: PubMed
    7. Montgomery RA, Orandi B, Racusen L, Jackson AM, Garonzik-Wang JM, Shah T, Woodle ES, Sommerer C, Fitts D, Rockich K, Zhang P, Uknis ME, et al. Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. Am J Transplant. 2016 May 16. PMID: 27184779.
      View in: PubMed
    8. Orandi B, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. N Engl J Med. 2016 Mar 10; 374(10):940-50. PMID: 26962729.
      View in: PubMed
    9. Axelrod D, Segev DL, Xiao H, Schnitzler MA, Brennan DC, Dharnidharka VR, Orandi B, Naik AS, Randall H, Tuttle-Newhall JE, Lentine KL. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients. Am J Transplant. 2016 May; 16(5):1465-73. PMID: 26603690.
      View in: PubMed
    10. Ahmed R, Lopez J, Bae S, Massie AB, Chow EK, Chopra K, Orandi B, Lonze BE, May JW, Sacks JM, Segev DL. Where the Sun Shines: Industry's Payments to Plastic Surgeons. Plast Reconstr Surg. 2015 Oct; 136(4 Suppl):58. PMID: 26397560.
      View in: PubMed
    11. Ahmed R, Chow EK, Massie AB, Anjum S, King EA, Orandi B, Bae S, Nicholas LH, Lonze BE, Segev DL. Where the Sun Shines: Industry's Payments to Transplant Surgeons. Am J Transplant. 2016 Jan; 16(1):292-300. PMID: 26317315.
      View in: PubMed
    12. Orandi B, Alachkar N, Kraus ES, Naqvi F, Lonze BE, Lees L, Van Arendonk KJ, Wickliffe C, Bagnasco SM, Zachary AA, Segev DL, Montgomery RA. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation. Am J Transplant. 2016 Jan; 16(1):213-20. PMID: 26317487.
      View in: PubMed
    13. Orandi B, James NT, Hall EC, Van Arendonk KJ, Garonzik-Wang JM, Gupta N, Montgomery RA, Desai NM, Segev DL. Center-level variation in the development of delayed graft function after deceased donor kidney transplantation. Transplantation. 2015 May; 99(5):997-1002. PMID: 25340600; PMCID: PMC4405384 [Available on 05/01/16].
    14. McAdams-DeMarco MA, Law A, Tan J, Delp C, King EA, Orandi B, Salter M, Alachkar N, Desai N, Grams M, Walston J, Segev DL. Frailty, mycophenolate reduction, and graft loss in kidney transplant recipients. Transplantation. 2015 Apr; 99(4):805-10. PMID: 25393156; PMCID: PMC4382409 [Available on 04/01/16].
    15. Van Arendonk KJ, Chow EK, James NT, Orandi B, Ellison TA, Smith JM, Colombani PM, Segev AD. Choosing the order of deceased donor and living donor kidney transplantation in pediatric recipients: a Markov decision process model. Transplantation. 2015 Feb; 99(2):360-6. PMID: 25594552; PMCID: PMC4320004 [Available on 02/01/16].
    16. Van Arendonk KJ, King EA, Orandi B, James NT, Smith JM, Colombani PM, Magee JC, Segev DL. Loss of pediatric kidney grafts during the "high-risk age window": insights from pediatric liver and simultaneous liver-kidney recipients. Am J Transplant. 2015 Feb; 15(2):445-52. PMID: 25612497; PMCID: PMC4327777 [Available on 02/01/16].
    17. Orandi B, Chow EH, Hsu A, Gupta N, Van Arendonk KJ, Garonzik-Wang JM, Montgomery JR, Wickliffe C, Lonze BE, Bagnasco SM, Alachkar N, Kraus ES, Jackson AM, Montgomery RA, Segev DL. Quantifying renal allograft loss following early antibody-mediated rejection. Am J Transplant. 2015 Feb; 15(2):489-98. PMID: 25611786; PMCID: PMC4304875 [Available on 02/01/16].
    18. Orandi B, Zachary AA, Dagher NN, Bagnasco SM, Garonzik-Wang JM, Van Arendonk KJ, Gupta N, Lonze BE, Alachkar N, Kraus ES, Desai NM, Locke JE, Racusen LC, Segev DL, Montgomery RA. Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation. 2014 Oct 27; 98(8):857-63. PMID: 25121475.
      View in: PubMed
    19. Orandi B, Selvarajah S, Orion KC, Lum YW, Perler BA, Abularrage CJ. Outcomes of nonelective weekend admissions for lower extremity ischemia. J Vasc Surg. 2014 Dec; 60(6):1572-9.e1. PMID: 25441678.
      View in: PubMed
    20. Salter ML, Orandi B, McAdams-DeMarco MA, Law A, Meoni LA, Jaar BG, Sozio SM, Kao WH, Parekh RS, Segev DL. Patient- and provider-reported information about transplantation and subsequent waitlisting. J Am Soc Nephrol. 2014 Dec; 25(12):2871-7. PMID: 25168028; PMCID: PMC4243357 [Available on 12/01/15].
    21. Jackson AM, Kraus ES, Orandi B, Segev DL, Montgomery RA, Zachary AA. A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation. Kidney Int. 2015 Feb; 87(2):409-16. PMID: 25054778; PMCID: PMC4305036.
    22. Orandi B, Garonzik-Wang JM, Massie AB, Zachary AA, Montgomery JR, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL. Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant. 2014 Jul; 14(7):1573-80. PMID: 24913913.
      View in: PubMed
    23. Van Arendonk KJ, Boyarsky BJ, Orandi B, James NT, Smith JM, Colombani PM, Segev DL. National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics. 2014 Apr; 133(4):594-601. PMID: 24616363; PMCID: PMC4530294.
    24. Lonze BE, Zachary AA, Magro CM, Desai NM, Orandi B, Dagher NN, Singer AL, Carter-Monroe N, Nazarian SM, Segev DL, Streiff MB, Montgomery RA. Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. Am J Transplant. 2014 Feb; 14(2):459-65. PMID: 24400968.
      View in: PubMed
    25. Van Arendonk KJ, James NT, Orandi B, Garonzik-Wang JM, Smith JM, Colombani PM, Segev DL. Order of donor type in pediatric kidney transplant recipients requiring retransplantation. Transplantation. 2013 Sep 15; 96(5):487-93. PMID: 24002689; PMCID: PMC3763240.
    26. Van Arendonk KJ, Orandi B, James NT, Segev DL, Colombani PM. Living unrelated renal transplantation: a good match for the pediatric candidate? J Pediatr Surg. 2013 Jun; 48(6):1277-82. PMID: 23845618.
      View in: PubMed
    27. Van Arendonk KJ, James NT, Boyarsky BJ, Garonzik-Wang JM, Orandi B, Magee JC, Smith JM, Colombani PM, Segev DL. Age at graft loss after pediatric kidney transplantation: exploring the high-risk age window. Clin J Am Soc Nephrol. 2013 Jun; 8(6):1019-26. PMID: 23430210; PMCID: PMC3675856.
    28. Garonzik-Wang JM, James NT, Van Arendonk KJ, Gupta N, Orandi B, Hall EC, Massie AB, Montgomery RA, Dagher NN, Singer AL, Cameron AM, Segev DL. The aggressive phenotype revisited: utilization of higher-risk liver allografts. Am J Transplant. 2013 Apr; 13(4):936-42. PMID: 23414232.
      View in: PubMed
    29. Housri N, Coombs M, Orandi B, Pawlik TM, Koniaris LG. Ethics and the law: is there common ground on informed consent for disparities in hospital outcomes? Ann Intern Med. 2011 Aug 16; 155(4):260-4. PMID: 21844552.
      View in: PubMed
    30. Orandi B, Blackburn S, Henke PK. Surgical mentors' and mentees' productivity from 1993 to 2006. Am J Surg. 2011 Feb; 201(2):260-5. PMID: 20883973.
      View in: PubMed
    31. Sharma KV, Dreher MR, Tang Y, Pritchard W, Chiesa OA, Karanian J, Peregoy J, Orandi B, Woods D, Donahue D, Esparza J, Jones G, Willis SL, Lewis AL, Wood BJ. Development of "imageable" beads for transcatheter embolotherapy. J Vasc Interv Radiol. 2010 Jun; 21(6):865-76. PMID: 20494290; PMCID: PMC2876341.
    32. Orandi B, Dimick JB, Deeb GM, Patel HJ, Upchurch GR. A population-based analysis of endovascular versus open thoracic aortic aneurysm repair. J Vasc Surg. 2009 May; 49(5):1112-6. PMID: 19307086.
      View in: PubMed
    33. Orandi B. The escalating importance of clinical research. Virtual Mentor. 2009; 11(4):277-8. PMID: 23195057.
      View in: PubMed
    34. Linguraru MG, Orandi B, Van Uitert RL, Mukherjee N, Summers RM, Gladwin MT, Machado RF, Wood BJ. CT and image processing non-invasive indicators of sickle cell secondary pulmonary hypertension. Conf Proc IEEE Eng Med Biol Soc. 2008; 2008:859-62. PMID: 19162792; PMCID: PMC2656258.
    Babak's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP